{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T01:49:33Z","timestamp":1785721773933,"version":"3.56.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>Physical therapy (PT) has been shown to be a helpful intervention in the treatment of chemotherapy-induced peripheral neuropathy (CIPN). Our aim was to screen for CIPN in patients with hematologic malignancies receiving vincristine chemotherapy and obtain a baseline assessment on the percentage of patients utilizing PT in the treatment of CIPN. A retrospective review of surveys administered to parents and patients regarding the severity of peripheral neuropathy symptoms from October 2016 through March 2018 was conducted. Of 116 patients, a total of 102 patients (67 male and 35 female; 4 to 10\u2009y of age, N=63; 11 to 15\u2009y of age, N=19; 16 to 20\u2009y of age, N=20) were eligible for the study, with 67.6% (N=69) reporting symptoms of CIPN. Of these patients, 16.7% scored 4 or greater on the surveys, suggesting clinically severe CIPN. Common parental concerns included decreased strength, difficulty walking up stairs, tripping, and foot drops. Approximately 55.1% of the 69 patients who reported CIPN symptoms were referred to outpatient PT, while 44.9% were not referred. A simple survey consisting of 4 questions that only took several minutes to administer was capable of identifying CIPN in 67.6% of patients receiving vincristine chemotherapy.<\/jats:p>","DOI":"10.1097\/mph.0000000000002202","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T04:42:09Z","timestamp":1621312929000},"page":"e358-e361","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Screening for Chemotherapy-induced Peripheral Neuropathy and Utilization of Physical Therapy in Pediatric Patients Receiving Treatment for Hematologic Malignancies"],"prefix":"10.1097","volume":"44","author":[{"given":"Cassandra P.","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of California-San Diego School of Medicine, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashette","family":"Syrkin-Nikolau","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California-San Diego School of Medicine, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauge","family":"Farnaes","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Physical Therapy, Rady Children\u2019s Hospital San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kanegaye","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology-Oncology, Rady Children\u2019s Hospital San Diego, University of California, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Kuo","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology-Oncology, Rady Children\u2019s Hospital San Diego, University of California, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"R1-20250805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20061451","article-title":"Mechanisms of chemotherapy-induced peripheral neuropathy","volume":"20","author":"Zaj\u0105czkowska","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R2-20250805","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0887-8994(95)00191-3","article-title":"Vincristine therapy for children with acute lymphoblastic leukemia impairs conduction in the entire peripheral nerve","volume":"13","author":"Vainionp\u00e4\u00e4","year":"1995","journal-title":"Pediatr Neurol"},{"key":"R3-20250805","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1529-8027.2008.00156.x","article-title":"Chemotherapy-induced neuropathy","volume":"13","author":"Windebank","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"R4-20250805","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/08880010903580209","article-title":"Physician referral frequency for physical therapy in children with acute lymphoblastic leukemia","volume":"27","author":"Gohar","year":"2010","journal-title":"Pediatr Hematol Oncol"},{"key":"R5-20250805","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/mpo.10266","article-title":"Strength and functional mobility in children with acute lymphoblastic leukemia","volume":"40","author":"Gocha marchese","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"R6-20250805","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/(SICI)1096-911X(199912)33:6<545::AID-MPO4>3.0.CO;2-Y","article-title":"Motor performance of children during treatment for acute lymphoblastic leukemia","volume":"33","author":"Reinders-messelink","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"R7-20250805","first-page":"186","article-title":"The orthopaedic presentation of acute leukaemia in childhood","volume":"83","author":"Chell","year":"2001","journal-title":"Ann R Coll Surg Engl"},{"key":"R8-20250805","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780150610","article-title":"The arthritis of leukaemia","volume":"15","author":"Spilberg","year":"1972","journal-title":"Arthritis Rheum"},{"key":"R9-20250805","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s002470050201","article-title":"Effects of pediatric cancer therapy on the musculoskeletal system","volume":"27","author":"Fletcher","year":"1997","journal-title":"Pediatr Radiol"},{"key":"R10-20250805","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/pbc.10481","article-title":"Effects of physical therapy intervention for children with acute lymphoblastic leukemia","volume":"42","author":"Marchese","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20250805","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1249\/01.mss.0000240326.54147.fc","article-title":"Effects of an intrahospital exercise program intervention for children with leukemia","volume":"39","author":"San juan","year":"2007","journal-title":"Med Sci Sports Exerc"},{"key":"R12-20250805","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1043454217698093","article-title":"The stoplight program: a proactive physical therapy intervention for children with acute lymphoblastic leukemia","volume":"34","author":"Tanner","year":"2017","journal-title":"J Pediatr Oncol Nurs"},{"key":"R13-20250805","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11864-014-0303-7","article-title":"Therapeutic strategies for cancer treatment related peripheral neuropathies","volume":"15","author":"Pachman","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"R14-20250805","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/pbc.22882","article-title":"Dactinomycin and vincristine toxicity in the treatment of childhood cancer: a retrospective study from the Children\u2019s Oncology Group","volume":"57","author":"Langholz","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R15-20250805","first-page":"1","article-title":"Chemotherapy-induced peripheral neuropathy in pediatric cancer patients","volume":"5","author":"Moore","year":"2013","journal-title":"Cureus"},{"key":"R16-20250805","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ctrv.2016.09.005","article-title":"Pediatric chemotherapy induced peripheral neuropathy: a systematic review of current knowledge","volume":"50","author":"Kandula","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"R17-20250805","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/jns.12114","article-title":"Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia","volume":"20","author":"Lavoie Smith","year":"2015","journal-title":"J Peripher Nerv Syst"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T01:00:34Z","timestamp":1754355634000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002202","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"2020-10-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}